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Background: Herpes simplex virus (HSV) is a common cause
of ulcerative mucocutaneous disease in both immunocompetent
and immunocompromised individuals. HSV-1 is usually acquired
in childhood and causes oral ulcers, whereas HSV-2 is sexually
transmitted and causes anogenital ulcers. The rates of prevalence of
HSV-1 and 2 differ widely between and within countries; however
the occurrence of HSV1 and 2 among HIV patients in the Northern
part of South Africa has not been thoroughly investigated.
Methods & Materials: In order to determine the prevalence
and risk factors of HSV1 and 2, urine samples were collected from
HIV and AIDS patients attending different treatment centers in the
Limpopo Province. Total genomic DNA was isolated from these
samples using the Qiagen Blood Mini Kit and a real time PCR proto-
col was used for the detection of HSV1 and 2 in the urine samples.
Demographic data, clinical and socioeconomic status data were
collected from the patients using a structured questionnaire.
Results: The overall prevalence of HSV1 was 52.4% while that
of HSV2 was 10.8% from a total of 308 samples. The prevalence of
HSV1 was higher among females while that of HSV2 did not vary
between males and females. The prevalence of both viruses in the
urine increased with age although the difference was not signiﬁ-
cant. Patients on zidovudine had a much lower prevalence while
those on stavudine had higher prevalence. Patients who had TB (2
=9.128; p=0.003), seemed to have a much higher susceptibility to
HSV1 however, this was not the case with HSV2. CD4 count and
viral load did not seem to have any impact of the occurrence of
HSV among these patients.
Conclusion: Generally, history of TB and early age of sexual
debut appeared to be the important risk factors while the use of
certain ARVswas protective again HSV1 infections. The high recov-
ery rate obtained in this study demonstrates the importance of
employing real-time PCR techniques in the diagnosis of the HSV
using urine samples. It is also suggested that for research settings
inwhich vaginal swab specimens are not available urine-based PCR
may be useful for the detection of HSV1 and 2 in HIV patients.
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Role of Neisseria meningitidis W135 in the
cerebrospinal meningitis outbreak in Senegal in
2012: Epidemiological and biological
characteristics
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Background: Since the ﬁrst large-scale epidemic in 2002,
Neisseria meningitidis serogroup W135 has been responsible for
repeated outbreaks of cerebrospinal meningitis in countries of the
meningitis belt. Although no epidemics have been noted in Sene-
gal, sporadic cases of meningitis caused by N. meningitidis have
been conﬁrmed. The objective of this studywas to describe the epi-
demiological and biological characteristics of the meningitis cases
reported during the cerebrospinal meningitis outbreak in Senegal
in 2012, with an aim to deﬁne the role of N. meningitidis W135.
Methods & Materials: We conducted a descriptive retrospec-
tive study of the 2012 meningitis outbreak in Senegal. Data was
collected from the weekly notiﬁcation sheets of suspected and
conﬁrmed meningitis cases reported to the Division of Preventive
Medicineof theMinistryofHealth.Continuous surveillance isongo-
ing and all cases from the 14 regions of Senegal are reported to
the Ministry of Health. WHO case deﬁnitions and epidemiological
thresholds were used to conﬁrm cases and monitor the outbreak.
Results: A total of 895 cases were reported in the 76 health dis-
tricts of Senegal in 2012. Of these, 776 cases (86.8%) were reported
between March and July, the period of the outbreak. The peak was
noted in April (35.8% of cases), and in S6 (10.3%). The region of
Diourbel recorded the majority of cases (32.4%) with its District of
Touba reporting the highest number of cases (150 cases). The high-
est attack rates were recorded in the district of Diofﬁor (25.2%) and
in the Kaolack region (17.7%). Nioro, Kédougou and Foundiougne
districts recorded WHO threshold levels for alert, but no districts
recorded WHO threshold for an outbreak. The average age was
10.7 years [IQT 5months - 96years], with 67.3% of subjects aged
below 10years. Of the 113 cases conﬁrmed by bacteriology, 100
(88.5%) cases were caused by N. meningitidis W135. Twenty-eight
deaths were recorded, representing a case fatality of 24.8% among
conﬁrmed cases.
Conclusion: The emergence of Neisseria meningitidis serogroup
W135 must be taken into account in current vaccine strategies,
considering its circulation in the population and mortality rate
among conﬁrmed meningitis cases observed during this outbreak.
http://dx.doi.org/10.1016/j.ijid.2014.03.733
